Figure S3 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Authors
Xiaofan Li (ORCID: https://orcid.org/0000-0002-4783-7372)
Figure S3 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Xiaofan Li, Millicent Embry, Cuong Tran, Gang Yin et al.
Topics
Synthesis and biological activity
article
Figure S3 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Xiaofan Li, Millicent Embry, Cuong Tran, Gang Yin, Cristina L. Abrahams, Jennifer Smith, Helena Kiefel, Alice Yam, Mark Armanini, Hans‐Peter Gerber, Genevive Hernandez, Sihong Zhou, Krishna Bajjuri, Danielle K. Lewis, Robert Yuan, Rhoneil Pena, Christine Cheng, Andrew McGeehan
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Figure S3 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death — Xiaofan Li, Millicent Embry, et al. · (2025) | TGRS Research Map | TGRS